BioCentury | Jan 16, 2014
Distillery Therapeutics

Indication: Cancer

...studies suggest inhibiting S100A14 could help treat HER2+ breast cancer. In primary HER2+ breast tumors, S100A14...
...tissue and correlated with poor prognosis. In HER2+ human breast cancer cell lines, siRNA against S100A14...
...HER2 activation and subsequent cell growth compared with a scrambled siRNA. Planned work includes testing S100A14...
Items per page:
1 - 1 of 1